Mirena: Just a contraceptive device? or A modality with diverse clinical applications !
- PMID: 36505540
- PMCID: PMC9730969
- DOI: 10.4103/jfmpc.jfmpc_2545_20
Mirena: Just a contraceptive device? or A modality with diverse clinical applications !
Abstract
Abnormal uterine bleeding is the most frequently encountered complaint of the reproductive-age women. Heavy menstrual blood loss is responsible for interfering with women's physical, emotional, social, and quality of life. Levonorgestrel-releasing intrauterine device (LNG-IUS) is a highly effective reversible form of contraception. Besides this, its role in the treatment of heavy menstrual bleeding (HMB), endometrial hyperplasia, early-stage endometrial cancers, and endometrial protection as a part of hormone replacement therapy (HRT) is very well studied. This review will revisit the role of LNG-IUS as a nonsurgical option in the management of HMB.
Keywords: Abnormal uterine bleed; Mirena; heavy menstrual bleed; hormone replacement therapy; levonorgestrel-releasing intrauterine device.
Copyright: © 2022 Journal of Family Medicine and Primary Care.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.Drug Saf. 1996 Dec;15(6):430-40. doi: 10.2165/00002018-199615060-00006. Drug Saf. 1996. PMID: 8968696 Review.
-
Endometrial ablation plus levonorgestrel releasing intrauterine system versus endometrial ablation alone in women with heavy menstrual bleeding: study protocol of a multicentre randomised controlled trial; MIRA2 trial.BMC Womens Health. 2022 Jun 27;22(1):257. doi: 10.1186/s12905-022-01843-6. BMC Womens Health. 2022. PMID: 35761328 Free PMC article.
-
Levonorgestrel-releasing intrauterine system versus endometrial ablation for heavy menstrual bleeding.Am J Obstet Gynecol. 2021 Feb;224(2):187.e1-187.e10. doi: 10.1016/j.ajog.2020.08.016. Epub 2020 Aug 12. Am J Obstet Gynecol. 2021. PMID: 32795428 Clinical Trial.
-
The levonorgestrel-releasing intrauterine system in heavy menstrual bleeding: a benefit-risk review.Drugs. 2012 Jan 22;72(2):193-215. doi: 10.2165/11598960-000000000-00000. Drugs. 2012. PMID: 22268392 Review.
-
The levonorgestrel intrauterine system versus endometrial ablation for heavy menstrual bleeding: a cost-effectiveness analysis.BJOG. 2021 Nov;128(12):2003-2011. doi: 10.1111/1471-0528.16836. Epub 2021 Jul 27. BJOG. 2021. PMID: 34245652 Free PMC article. Clinical Trial.
References
-
- Munro M G, Critchley H O D, Fraser I S. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynecol Obstet. 2018;143:393–408. - PubMed
-
- National Institute for Health and Care Excellence. Heavy menstrual bleeding: Assessment and management (Nice Guideline. No.88) 2018. [Last accessed on 2021 Oct 06]. Available from: https://www.nice.org.uk/guidance/ng88 . - PubMed
-
- Committee on Practice Bulletins—Gynecology. Practice bulletin no. 128: Diagnosis of abnormal uterine bleeding in reproductive-aged women. Obstet Gynecol. 2012;120:197–206. - PubMed
-
- Engstrom JL, Rose R, Brill AI, Polhill KM, Lukanich CM, Fritz L. Midwifery care of the woman with menorrhagia. J Nurse Midwifery. 1999;44:89–105. - PubMed
Publication types
LinkOut - more resources
Full Text Sources